chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Erythema, Pruritus, Vital signs measurement
Clinical narrative: some increased work of breathing/ hard to breath and it feels like i am unable to take a deep breath; redness to her left side of the neck; dizziness; itching to the left posterior neck; This is a spontaneous report from a contactable pharmacist. A 23-years-old female patient received bnt162b2 (BNT162B2, formulation: solution for injection, Lot Number: EN6201) via intramuscularly on 26Feb2021 12:30 as dose 2, single (at the age of 23-years-old) for COVID-19 immunization. Medical history included patient did have a reaction to the typhoid vaccine in the past with a noted peg allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took bnt162b2 via intramuscularly as dose 1, single for COVID-19 immunization and experienced urticaria, rash and pruritus. On 26Feb2021 at 12:33, the patient experienced dizziness, itching to the left posterior neck. At 12:35, patient experienced itching to the back and noticed some increased work of breathing and redness to her left side of the neck. Patient stated hard to breath and it feels like she was unable to take a deep breath. At 12:37 provider and medics on duty notified and patient assessed and patient's vss and lungs clear to auscultation and patient was given Benadryl 25 oral liquid mg by nurse. The patient underwent lab tests and procedures on 26Feb2021, VSS and lung investigation results auscultation. No therapeutic measures were taken. The outcome of the events was reported as unknown.  Follow-up attempts completed. No further information expected.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Erythema, Investigation, Pruritus
Clinical narrative: some increased work of breathing/ hard to breath and it feels like i am unable to take a deep breath; redness to her left side of the neck; dizziness; itching to the left posterior neck; This is a spontaneous report from a contactable pharmacist. A 23-years-old female patient received bnt162b2 (BNT162B2, formulation: solution for injection, Lot Number: EN6201) via intramuscularly on 26Feb2021 12:30 as dose 2, single (at the age of 23-years-old) for COVID-19 immunization. Medical history included patient did have a reaction to the typhoid vaccine in the past with a noted peg allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took bnt162b2 via intramuscularly as dose 1, single for COVID-19 immunization and experienced urticaria, rash and pruritus. On 26Feb2021 at 12:33, the patient experienced dizziness, itching to the left posterior neck. At 12:35, patient experienced itching to the back and noticed some increased work of breathing and redness to her left side of the neck. Patient stated hard to breath and it feels like she was unable to take a deep breath. At 12:37 provider and medics on duty notified and patient assessed and patient's vss and lungs clear to auscultation and patient was given Benadryl 25 oral liquid mg by nurse. The patient underwent lab tests and procedures on 26Feb2021, VSS and lung investigation results auscultation. No therapeutic measures were taken. The outcome of the events was reported as unknown.  Follow-up attempts completed. No further information expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Chills, Dizziness, Fatigue
Clinical narrative: Developed chills; muscle/joint pain; nausea; tiredness; fever; headache; dizziness; general weakness; This is the spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6201), via an unknown route of administration in left arm on 24Feb2021 at 07:15 (at the age of 67-years-old) as dose 2, single for COVID-19 immunisation at hospital. The patient's medical history included kidney stones in Dec 2021 and back issues resolved since oblation to spine done approx. 1.5 years ago. She was allergic to codeine. Concomitant medications included gabapentin (GABAPENTIN), acetylsalicylic acid (BABY ASPIRIN) and vitamin D NOS (VITAMIN D NOS); all were taken for an unknown indication from an unknown date. No other vaccine in four weeks. The patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EL9265), via an unknown route of administration in right arm on 03Feb2021 at 07:30 (at the age of 67-years-old) as historical vaccine as dose 1, single for COVID-19 immunisation. On 24Feb2021 at 20:00, the patient developed chills, muscle/joint pain, nausea, tiredness, fever, headache, dizziness and general weakness. No covid prior vaccination. No covid tested post vaccination. No treatment received. The outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gait disturbance, Headache, Malaise, Myalgia, Nausea
Clinical narrative: Developed chills; muscle/joint pain; nausea; tiredness; fever; headache; dizziness; general weakness; This is the spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6201), via an unknown route of administration in left arm on 24Feb2021 at 07:15 (at the age of 67-years-old) as dose 2, single for COVID-19 immunisation at hospital. The patient's medical history included kidney stones in Dec 2021 and back issues resolved since oblation to spine done approx. 1.5 years ago. She was allergic to codeine. Concomitant medications included gabapentin (GABAPENTIN), acetylsalicylic acid (BABY ASPIRIN) and vitamin D NOS (VITAMIN D NOS); all were taken for an unknown indication from an unknown date. No other vaccine in four weeks. The patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EL9265), via an unknown route of administration in right arm on 03Feb2021 at 07:30 (at the age of 67-years-old) as historical vaccine as dose 1, single for COVID-19 immunisation. On 24Feb2021 at 20:00, the patient developed chills, muscle/joint pain, nausea, tiredness, fever, headache, dizziness and general weakness. No covid prior vaccination. No covid tested post vaccination. No treatment received. The outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Developed chills; muscle/joint pain; nausea; tiredness; fever; headache; dizziness; general weakness; This is the spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6201), via an unknown route of administration in left arm on 24Feb2021 at 07:15 (at the age of 67-years-old) as dose 2, single for COVID-19 immunisation at hospital. The patient's medical history included kidney stones in Dec 2021 and back issues resolved since oblation to spine done approx. 1.5 years ago. She was allergic to codeine. Concomitant medications included gabapentin (GABAPENTIN), acetylsalicylic acid (BABY ASPIRIN) and vitamin D NOS (VITAMIN D NOS); all were taken for an unknown indication from an unknown date. No other vaccine in four weeks. The patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EL9265), via an unknown route of administration in right arm on 03Feb2021 at 07:30 (at the age of 67-years-old) as historical vaccine as dose 1, single for COVID-19 immunisation. On 24Feb2021 at 20:00, the patient developed chills, muscle/joint pain, nausea, tiredness, fever, headache, dizziness and general weakness. No covid prior vaccination. No covid tested post vaccination. No treatment received. The outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Developed chills; muscle/joint pain; nausea; tiredness; fever; headache; dizziness; general weakness; This is the spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6201), via an unknown route of administration in left arm on 24Feb2021 at 07:15 (at the age of 67-years-old) as dose 2, single for COVID-19 immunisation at hospital. The patient's medical history included kidney stones in Dec 2021 and back issues resolved since oblation to spine done approx. 1.5 years ago. She was allergic to codeine. Concomitant medications included gabapentin (GABAPENTIN), acetylsalicylic acid (BABY ASPIRIN) and vitamin D NOS (VITAMIN D NOS); all were taken for an unknown indication from an unknown date. No other vaccine in four weeks. The patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EL9265), via an unknown route of administration in right arm on 03Feb2021 at 07:30 (at the age of 67-years-old) as historical vaccine as dose 1, single for COVID-19 immunisation. On 24Feb2021 at 20:00, the patient developed chills, muscle/joint pain, nausea, tiredness, fever, headache, dizziness and general weakness. No covid prior vaccination. No covid tested post vaccination. No treatment received. The outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: Developed chills; muscle/joint pain; nausea; tiredness; fever; headache; dizziness; general weakness; This is the spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6201), via an unknown route of administration in left arm on 24Feb2021 at 07:15 (at the age of 67-years-old) as dose 2, single for COVID-19 immunisation at hospital. The patient's medical history included kidney stones in Dec 2021 and back issues resolved since oblation to spine done approx. 1.5 years ago. She was allergic to codeine. Concomitant medications included gabapentin (GABAPENTIN), acetylsalicylic acid (BABY ASPIRIN) and vitamin D NOS (VITAMIN D NOS); all were taken for an unknown indication from an unknown date. No other vaccine in four weeks. The patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EL9265), via an unknown route of administration in right arm on 03Feb2021 at 07:30 (at the age of 67-years-old) as historical vaccine as dose 1, single for COVID-19 immunisation. On 24Feb2021 at 20:00, the patient developed chills, muscle/joint pain, nausea, tiredness, fever, headache, dizziness and general weakness. No covid prior vaccination. No covid tested post vaccination. No treatment received. The outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Chills, Decreased appetite, Electrocardiogram normal, Fatigue
Clinical narrative: Extremely tired; headache; body/muscle aches; chills; fever(11 days now); nausea; no appetite (lost 12pounds); swollen lymph nodes; feels horrible; This is a spontaneous report from a contactable consumer. This 55-years-old male consumer(patient) reported for himself that:  A 55-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration in arm left on 18Feb2021 15:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunization. Medical history included complex regional pain syndrome and high blood pressure. Concomitant medications included amlodipine besylate (AMLODIPINE BESYLATE) taken for an unspecified indication, start and stop date were not reported; naproxen (NAPROXEN) taken for an unspecified indication, start and stop date were not reported; pregabalin (PREGABALIN) taken for an unspecified indication, start and stop date were not reported; losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported were taken 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was tested for COVID-19 (Nasal Swab) post vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Feb2021 at 6:00 patient was extremely tired, headache, body/muscle aches, chills, fever (11 days now), nausea, no appetite (lost 12pounds), swollen lymph nodes, feels horrible. The patient underwent lab tests and procedures which included post vaccination nasal swab and rapid test on 22Feb2021 both negative and Nasal swab on 24Feb2021: negative, chest X ray: unknown, EKG: Unknown. Patient received treatment of Tylenol and ibuprofen. The clinical outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Headache, Injection site pain, Lymphadenopathy, Myalgia
Clinical narrative: Extremely tired; headache; body/muscle aches; chills; fever(11 days now); nausea; no appetite (lost 12pounds); swollen lymph nodes; feels horrible; This is a spontaneous report from a contactable consumer. This 55-years-old male consumer(patient) reported for himself that:  A 55-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration in arm left on 18Feb2021 15:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunization. Medical history included complex regional pain syndrome and high blood pressure. Concomitant medications included amlodipine besylate (AMLODIPINE BESYLATE) taken for an unspecified indication, start and stop date were not reported; naproxen (NAPROXEN) taken for an unspecified indication, start and stop date were not reported; pregabalin (PREGABALIN) taken for an unspecified indication, start and stop date were not reported; losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported were taken 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was tested for COVID-19 (Nasal Swab) post vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Feb2021 at 6:00 patient was extremely tired, headache, body/muscle aches, chills, fever (11 days now), nausea, no appetite (lost 12pounds), swollen lymph nodes, feels horrible. The patient underwent lab tests and procedures which included post vaccination nasal swab and rapid test on 22Feb2021 both negative and Nasal swab on 24Feb2021: negative, chest X ray: unknown, EKG: Unknown. Patient received treatment of Tylenol and ibuprofen. The clinical outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Extremely tired; headache; body/muscle aches; chills; fever(11 days now); nausea; no appetite (lost 12pounds); swollen lymph nodes; feels horrible; This is a spontaneous report from a contactable consumer. This 55-years-old male consumer(patient) reported for himself that:  A 55-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration in arm left on 18Feb2021 15:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunization. Medical history included complex regional pain syndrome and high blood pressure. Concomitant medications included amlodipine besylate (AMLODIPINE BESYLATE) taken for an unspecified indication, start and stop date were not reported; naproxen (NAPROXEN) taken for an unspecified indication, start and stop date were not reported; pregabalin (PREGABALIN) taken for an unspecified indication, start and stop date were not reported; losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported were taken 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was tested for COVID-19 (Nasal Swab) post vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Feb2021 at 6:00 patient was extremely tired, headache, body/muscle aches, chills, fever (11 days now), nausea, no appetite (lost 12pounds), swollen lymph nodes, feels horrible. The patient underwent lab tests and procedures which included post vaccination nasal swab and rapid test on 22Feb2021 both negative and Nasal swab on 24Feb2021: negative, chest X ray: unknown, EKG: Unknown. Patient received treatment of Tylenol and ibuprofen. The clinical outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Chills, Decreased appetite, Electrocardiogram, Fatigue
Clinical narrative: Extremely tired; headache; body/muscle aches; chills; fever(11 days now); nausea; no appetite (lost 12pounds); swollen lymph nodes; feels horrible; This is a spontaneous report from a contactable consumer. This 55-years-old male consumer(patient) reported for himself that:  A 55-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration in arm left on 18Feb2021 15:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunization. Medical history included complex regional pain syndrome and high blood pressure. Concomitant medications included amlodipine besylate (AMLODIPINE BESYLATE) taken for an unspecified indication, start and stop date were not reported; naproxen (NAPROXEN) taken for an unspecified indication, start and stop date were not reported; pregabalin (PREGABALIN) taken for an unspecified indication, start and stop date were not reported; losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported were taken 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was tested for COVID-19 (Nasal Swab) post vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Feb2021 at 6:00 patient was extremely tired, headache, body/muscle aches, chills, fever (11 days now), nausea, no appetite (lost 12pounds), swollen lymph nodes, feels horrible. The patient underwent lab tests and procedures which included post vaccination nasal swab and rapid test on 22Feb2021 both negative and Nasal swab on 24Feb2021: negative, chest X ray: unknown, EKG: Unknown. Patient received treatment of Tylenol and ibuprofen. The clinical outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Headache, Lymphadenopathy, Myalgia, Nausea
Clinical narrative: Extremely tired; headache; body/muscle aches; chills; fever(11 days now); nausea; no appetite (lost 12pounds); swollen lymph nodes; feels horrible; This is a spontaneous report from a contactable consumer. This 55-years-old male consumer(patient) reported for himself that:  A 55-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration in arm left on 18Feb2021 15:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunization. Medical history included complex regional pain syndrome and high blood pressure. Concomitant medications included amlodipine besylate (AMLODIPINE BESYLATE) taken for an unspecified indication, start and stop date were not reported; naproxen (NAPROXEN) taken for an unspecified indication, start and stop date were not reported; pregabalin (PREGABALIN) taken for an unspecified indication, start and stop date were not reported; losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported were taken 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was tested for COVID-19 (Nasal Swab) post vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Feb2021 at 6:00 patient was extremely tired, headache, body/muscle aches, chills, fever (11 days now), nausea, no appetite (lost 12pounds), swollen lymph nodes, feels horrible. The patient underwent lab tests and procedures which included post vaccination nasal swab and rapid test on 22Feb2021 both negative and Nasal swab on 24Feb2021: negative, chest X ray: unknown, EKG: Unknown. Patient received treatment of Tylenol and ibuprofen. The clinical outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Extremely tired; headache; body/muscle aches; chills; fever(11 days now); nausea; no appetite (lost 12pounds); swollen lymph nodes; feels horrible; This is a spontaneous report from a contactable consumer. This 55-years-old male consumer(patient) reported for himself that:  A 55-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration in arm left on 18Feb2021 15:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunization. Medical history included complex regional pain syndrome and high blood pressure. Concomitant medications included amlodipine besylate (AMLODIPINE BESYLATE) taken for an unspecified indication, start and stop date were not reported; naproxen (NAPROXEN) taken for an unspecified indication, start and stop date were not reported; pregabalin (PREGABALIN) taken for an unspecified indication, start and stop date were not reported; losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported were taken 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was tested for COVID-19 (Nasal Swab) post vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Feb2021 at 6:00 patient was extremely tired, headache, body/muscle aches, chills, fever (11 days now), nausea, no appetite (lost 12pounds), swollen lymph nodes, feels horrible. The patient underwent lab tests and procedures which included post vaccination nasal swab and rapid test on 22Feb2021 both negative and Nasal swab on 24Feb2021: negative, chest X ray: unknown, EKG: Unknown. Patient received treatment of Tylenol and ibuprofen. The clinical outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling hot, Headache, Muscular weakness, Rash erythematous
Clinical narrative: scratchy throat; pains in my left temple that went across my forehead; Felt extremely hot; Red rash appeared on my face; I had weakness in my legs; was dizzy; This is a spontaneous report from a contactable Consumer (patient). A 66-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW6202), dose 1 via an unspecified route of administration, administered in Arm Left on 27Feb2021 at 12:00 PM as a single dose for covid-19 immunization (at the age of 66-years-old). Medical history included diabetes, kidney stones, severe neuropathy, and known allergies: Penicillin. Concomitant medications included losartan potassium (COZAAR); hydrochlorothiazide, simvastatin (ZOCOR), oxycodone hydrochloride, oxycodone terephthalate, paracetamol taken for an unspecified indication. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Patient did not receive other vaccine within 4 weeks prior to the COVID vaccine. Patient took Benedryl treatment for reported events. The patient experienced within 3-5 minutes, on 27feb2021 at 12:15 pm, patient got severe shooting pains in her left temple that went across her forehead with headache, felt extremely hot and red rash appeared on my face on both cheeks and when she got up to leave she had weakness in her legs and was dizzy. still had pain in left temple, headache, rash and dizziness the next day along with scratchy throat on 28feb2021. headache and pain in temple mild after 3 days. patient was concerned about second dose only because of shooting pains in her left temple. The outcome of all the events was recovering.  No follow-up attempts are possible; No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation
Clinical narrative: scratchy throat; pains in my left temple that went across my forehead; Felt extremely hot; Red rash appeared on my face; I had weakness in my legs; was dizzy; This is a spontaneous report from a contactable Consumer (patient). A 66-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW6202), dose 1 via an unspecified route of administration, administered in Arm Left on 27Feb2021 at 12:00 PM as a single dose for covid-19 immunization (at the age of 66-years-old). Medical history included diabetes, kidney stones, severe neuropathy, and known allergies: Penicillin. Concomitant medications included losartan potassium (COZAAR); hydrochlorothiazide, simvastatin (ZOCOR), oxycodone hydrochloride, oxycodone terephthalate, paracetamol taken for an unspecified indication. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Patient did not receive other vaccine within 4 weeks prior to the COVID vaccine. Patient took Benedryl treatment for reported events. The patient experienced within 3-5 minutes, on 27feb2021 at 12:15 pm, patient got severe shooting pains in her left temple that went across her forehead with headache, felt extremely hot and red rash appeared on my face on both cheeks and when she got up to leave she had weakness in her legs and was dizzy. still had pain in left temple, headache, rash and dizziness the next day along with scratchy throat on 28feb2021. headache and pain in temple mild after 3 days. patient was concerned about second dose only because of shooting pains in her left temple. The outcome of all the events was recovering.  No follow-up attempts are possible; No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Feeling hot, Headache, Rash
Clinical narrative: scratchy throat; pains in my left temple that went across my forehead; Felt extremely hot; Red rash appeared on my face; I had weakness in my legs; was dizzy; This is a spontaneous report from a contactable Consumer (patient). A 66-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW6202), dose 1 via an unspecified route of administration, administered in Arm Left on 27Feb2021 at 12:00 PM as a single dose for covid-19 immunization (at the age of 66-years-old). Medical history included diabetes, kidney stones, severe neuropathy, and known allergies: Penicillin. Concomitant medications included losartan potassium (COZAAR); hydrochlorothiazide, simvastatin (ZOCOR), oxycodone hydrochloride, oxycodone terephthalate, paracetamol taken for an unspecified indication. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Patient did not receive other vaccine within 4 weeks prior to the COVID vaccine. Patient took Benedryl treatment for reported events. The patient experienced within 3-5 minutes, on 27feb2021 at 12:15 pm, patient got severe shooting pains in her left temple that went across her forehead with headache, felt extremely hot and red rash appeared on my face on both cheeks and when she got up to leave she had weakness in her legs and was dizzy. still had pain in left temple, headache, rash and dizziness the next day along with scratchy throat on 28feb2021. headache and pain in temple mild after 3 days. patient was concerned about second dose only because of shooting pains in her left temple. The outcome of all the events was recovering.  No follow-up attempts are possible; No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Electrocardiogram, Flushing, Pharyngeal swelling
Clinical narrative: throat fullness; cough; flush; throat swelling; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 38 year old male patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Left on 01Mar2021 17:45 (Batch/Lot Number: EN6198) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included rubber sensitivity to latex from an unknown date and unknown if ongoing, hypertension from an unknown date and unknown if ongoing, gout from an unknown date and unknown if ongoing. Concomitant medication(s) included allopurinol (ALLOPURINOL) taken for an unspecified indication, start and stop date were not reported; sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported; amlodipine (AMLODIPINE) taken for an unspecified indication, start and stop date were not reported; simvastatin (SIMVASTATIN) taken for an unspecified indication, start and stop date were not reported. The patient experienced throat fullness with sensation of foreign body on 01Mar2021 18:00 with outcome of recovered, cough on 01Mar2021 18:00 with outcome of recovered, flush on 01Mar2021 18:00 with outcome of recovered, throat swelling causing pharyngeal swelling on 01Mar2021 18:00 with outcome of recovered. The patient underwent lab tests and procedures which included electrocardiogram: unknown   on 01Mar2021.  Therapeutic measures were taken as a result of these events. Patient was examined by a nurse who referred him to the Emergency department for further evaluation. Patient was hydrated with NS and medicated with diphenhydramine IV for throat swelling and Dexamethasone IV for cough. Patient was mentioned for about one hour until resolution of symptoms. Medical tests and laboratory results related to the adverse event(s): EKG performed in ED and vital signs monitored.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Electrocardiogram, Flushing, Pharyngeal swelling, Sensation of foreign body
Clinical narrative: throat fullness; cough; flush; throat swelling; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 38 year old male patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Left on 01Mar2021 17:45 (Batch/Lot Number: EN6198) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included rubber sensitivity to latex from an unknown date and unknown if ongoing, hypertension from an unknown date and unknown if ongoing, gout from an unknown date and unknown if ongoing. Concomitant medication(s) included allopurinol (ALLOPURINOL) taken for an unspecified indication, start and stop date were not reported; sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported; amlodipine (AMLODIPINE) taken for an unspecified indication, start and stop date were not reported; simvastatin (SIMVASTATIN) taken for an unspecified indication, start and stop date were not reported. The patient experienced throat fullness with sensation of foreign body on 01Mar2021 18:00 with outcome of recovered, cough on 01Mar2021 18:00 with outcome of recovered, flush on 01Mar2021 18:00 with outcome of recovered, throat swelling causing pharyngeal swelling on 01Mar2021 18:00 with outcome of recovered. The patient underwent lab tests and procedures which included electrocardiogram: unknown   on 01Mar2021.  Therapeutic measures were taken as a result of these events. Patient was examined by a nurse who referred him to the Emergency department for further evaluation. Patient was hydrated with NS and medicated with diphenhydramine IV for throat swelling and Dexamethasone IV for cough. Patient was mentioned for about one hour until resolution of symptoms. Medical tests and laboratory results related to the adverse event(s): EKG performed in ED and vital signs monitored.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Mobility decreased, Sleep disorder
Clinical narrative: Left shoulder in so much pain, unable to use due to pain; This is a spontaneous report from a contactable consumer (patient).  A 72-year-old male patient received bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 01Mar2021 12:30 at the age of 72-year-old as dose 2, single for covid-19 immunisation.  The patient medical history was none and no known allergies. The patient previously received bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration, on unspecified date as dose 1, single for covid-19 immunisation. The patient was not diagnosed with covid prior to vaccination and patient was not tested for COVID-19 post vaccination. Concomitant medications included tamsulosin, atorvastatin, oxybutynin taken for an unspecified indication, start and stop date were not reported.  The patient experienced left shoulder in so much pain, unable to use due to pain on 03Mar2021 08:00. The patient did not receive any treatment in response to the events.  The outcome of the vent was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 72.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Arthralgia
Clinical narrative: Left shoulder in so much pain, unable to use due to pain; This is a spontaneous report from a contactable consumer (patient).  A 72-year-old male patient received bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 01Mar2021 12:30 at the age of 72-year-old as dose 2, single for covid-19 immunisation.  The patient medical history was none and no known allergies. The patient previously received bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration, on unspecified date as dose 1, single for covid-19 immunisation. The patient was not diagnosed with covid prior to vaccination and patient was not tested for COVID-19 post vaccination. Concomitant medications included tamsulosin, atorvastatin, oxybutynin taken for an unspecified indication, start and stop date were not reported.  The patient experienced left shoulder in so much pain, unable to use due to pain on 03Mar2021 08:00. The patient did not receive any treatment in response to the events.  The outcome of the vent was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: Noticeable Rash developed on upper part of both legs, arms and front portion of neck.  Never on the torso.; This is a spontaneous report from a contactable consumer reported for herself that. A 50-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration,administered in Arm Left on 01Mar2021 13:15 (Batch/Lot Number: EW6203) as DOSE 1 SINGLE for covid-19 immunization(Age at vaccination 50 years). The patient past Medical history included Hiatal Hernia from an unknown date and unknown if ongoing and Penicillin allergy from an unknown date and unknown if ongoing. There were no concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. On 01Mar2021 13:30, the patient experienced noticeable rash developed on upper part of both legs, arms and front portion of neck.  never on the torso. No treatment was received. The event outcome was recovered on unspecified date in Mar2021.  No follow up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Flushing, Inflammation, Paraesthesia, Pruritus
Clinical narrative: itching; rash; flushing; inflamed throat; decreased respiration; This is a spontaneous report from a contactable other healthcare professional (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6202), via an unspecified route of administration in left arm on 03Mar2021 10:45 (at the age of 42-years-old) as dose 1, single for COVID-19 immunization. Medical history included Hashimotos thyroiditis and anxiety. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not having any known allergies. Concomitant medication included prescription medications. The patient was not pregnant. The patient experienced itching, rash, flushing, inflamed throat, and decreased respiration on 03Mar2021 11:15. Patient received treatment with Benadryl. No treatment was received for the event. Outcome of event was resolving.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous, Respiratory tract irritation, Throat irritation
Clinical narrative: itching; rash; flushing; inflamed throat; decreased respiration; This is a spontaneous report from a contactable other healthcare professional (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6202), via an unspecified route of administration in left arm on 03Mar2021 10:45 (at the age of 42-years-old) as dose 1, single for COVID-19 immunization. Medical history included Hashimotos thyroiditis and anxiety. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not having any known allergies. Concomitant medication included prescription medications. The patient was not pregnant. The patient experienced itching, rash, flushing, inflamed throat, and decreased respiration on 03Mar2021 11:15. Patient received treatment with Benadryl. No treatment was received for the event. Outcome of event was resolving.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flushing, Pharyngeal inflammation, Pruritus, Rash, Respiratory rate decreased
Clinical narrative: itching; rash; flushing; inflamed throat; decreased respiration; This is a spontaneous report from a contactable other healthcare professional (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6202), via an unspecified route of administration in left arm on 03Mar2021 10:45 (at the age of 42-years-old) as dose 1, single for COVID-19 immunization. Medical history included Hashimotos thyroiditis and anxiety. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not having any known allergies. Concomitant medication included prescription medications. The patient was not pregnant. The patient experienced itching, rash, flushing, inflamed throat, and decreased respiration on 03Mar2021 11:15. Patient received treatment with Benadryl. No treatment was received for the event. Outcome of event was resolving.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Lip dry, Lip swelling, Paraesthesia oral
Clinical narrative: top lip was swollen/within 2 hours,both upper and lower lips were swollen; numbness; Lips feel very dry; tingling sensation; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6198), via an unspecified route of administration, administered in left arm on 25Feb2021 14:00 (at the age of 67 year old) as dose 2, single for COVID-19 immunisation.  Medical history reported as none. Patient has known allergies to PCN.  Concomitant medication included omeprazole taken for an unspecified indication. The patient was not pregnant at the time of vaccination. Prior vaccination, patient was not diagnosed with COVID and did not receive any other vaccines within 2 weeks. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE,  lot number: EL9265), via an unspecified route of administration on 04Feb2021 14:00 (at the age of 67 year old), as single dose for COVID-19 immunization. On  01Mar2021, patient woke up at 05:00, feeling like her top lip was swollen, within 2 hours, both upper and lower lips were swollen, and then had moderate numbness. Lips felt very dry, swollen with moderate numbness and tingling sensation. Since vaccination patient had not tested for COVID. No treatment was received in response to the events. The outcome of the event was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Contusion
Clinical narrative: A medium size bruise on my LEFT HAND on the same arm where I was vaccinated.  Within 1 hour.; This is a spontaneous report from a contactable consumer or other non hcp (female consumer). A 60-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: EN6205), via an unspecified route of administration, administered in Arm Left on 05Mar2021 13:45 as 1st dose, single for covid-19 immunisation (age at vaccination was 60 years) patient was not pregnant at the time of vaccination. Known allergies was penicillin. Medical history included depression from an unknown date and unknown if ongoing. No, other vaccine in four weeks.Concomitant medication(s) included fluoxetine (FLUOXETINE) taken for an unspecified indication, start and stop date were not reported; alprazolam (ALPRAZOLAM) taken for an unspecified indication, start and stop date were not reported; fish oil (FISH OIL) taken for an unspecified indication, start and stop date were not reported; fluticasone propionate (FLONASE ALLERGY RELIEF) taken for an unspecified indication, start and stop date were not reported; ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported.  The patient experienced a medium size bruise on my left hand on the same arm where i was vaccinated.  within 1 hour on 05Mar2021 02:30. Treatment was not received. No, covid prior vaccination, no covid tested post for vaccination. Outcome of not recovered.    No follow-up attempts are possible. No further information is expected
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site bruising
Clinical narrative: A medium size bruise on my LEFT HAND on the same arm where I was vaccinated.  Within 1 hour.; This is a spontaneous report from a contactable consumer or other non hcp (female consumer). A 60-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: EN6205), via an unspecified route of administration, administered in Arm Left on 05Mar2021 13:45 as 1st dose, single for covid-19 immunisation (age at vaccination was 60 years) patient was not pregnant at the time of vaccination. Known allergies was penicillin. Medical history included depression from an unknown date and unknown if ongoing. No, other vaccine in four weeks.Concomitant medication(s) included fluoxetine (FLUOXETINE) taken for an unspecified indication, start and stop date were not reported; alprazolam (ALPRAZOLAM) taken for an unspecified indication, start and stop date were not reported; fish oil (FISH OIL) taken for an unspecified indication, start and stop date were not reported; fluticasone propionate (FLONASE ALLERGY RELIEF) taken for an unspecified indication, start and stop date were not reported; ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported.  The patient experienced a medium size bruise on my left hand on the same arm where i was vaccinated.  within 1 hour on 05Mar2021 02:30. Treatment was not received. No, covid prior vaccination, no covid tested post for vaccination. Outcome of not recovered.    No follow-up attempts are possible. No further information is expected
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Decreased appetite, Diarrhoea, Hyperhidrosis, Malaise, Pallor
Clinical narrative: dizziness/very dizzy; vomiting; having cold sweats; This is a spontaneous report received from a contactable Consumer or other non-HCP (patient reported for herself). The report was not related to a study or programme. A 21-year-old adult female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EN6204, Expiration date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 12Mar2021 at 18:00 (at the age of 21-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Patient medical history was None. Family Medical History Relevant to AEs was none. The patient concomitant medications were not reported. Prior Vaccinations within 4 weeks was none. On 15Mar2021, the patient experienced dizziness/very dizzy, vomiting and having cold sweats. The clinical details of the events as follows: caller stated she was calling about the Pfizer COVID vaccine and stated she had a few questions stated she had her 1st dose of the Pfizer COVID Vaccine on Friday evening on 12Mar2021 and today she had a pretty adverse event of being very dizzy having cold sweats and vomiting that began today 15Mar2021. Caller stated she did not believe the dizziness. cold sweats and vomiting are ongoing and stated she did not have treatment. Caller stated the symptoms were not pleasant and was asking if those were typical side effects with the Pfizer COVID Vaccine. Caller stated her 2nd question was that she was asking if it is safe to get the 2nd dose of the Pfizer COVID Vaccine in regard to the symptoms she has reported. Caller aware that Pfizer unable to offer treatment recommendations or medical advice; caller referred to her HCP. The AEs did not require a visit to Emergency Room and Physician Office. The events did not Result in death, Life threatening, caused prolonged hospitalization, Disabling Incapacitating and Congenital anomaly or birth defect. Relevant Tests were None. There was no Investigation Assessment provided. The case was reported as non-serious. The patient outcome of the events vomiting and having cold sweats was not resolved and the outcome of other event was unknown at the time of this report.  Follow-up attempts completed. No further information expected.